Can we safely continue to offer surgical treatments during the COVID-19 pandemic?
Open Access
- 20 November 2020
- journal article
- editorial
- Published by BMJ in BMJ Quality & Safety
- Vol. 30 (4) , 268-270
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling studyThe Lancet Oncology, 2020
- Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemicAnnals of Oncology, 2020
- Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort studyThe Lancet, 2020
- Resource requirements for reintroducing elective surgery in England during the COVID-19 pandemic: a modelling studymedRxiv, 2020
- Face masks for the public during the covid-19 crisisBMJ, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Age of patients undergoing surgeryBritish Journal of Surgery, 2019
- Frequency of surgical treatment and related hospital procedures in the UK: a national ecological study using hospital episode statisticsBritish Journal of Anaesthesia, 2017
- Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomesThe Lancet, 2015
- Prediction of Postoperative Pulmonary Complications in a Population-based Surgical CohortAnesthesiology, 2010